Coordination of COVID-19 Research
Leadership at the University of Pittsburgh and UPMC has designated the Clinical and Translational Science Institute as the central hub for collecting information and providing resources related to COVID-19 research studies (see full announcement below). This directive applies to any and all research studies that require HRPO (IRB) approval.
If your research team at the University of Pittsburgh or UPMC is 1) currently conducting COVID-19 research; 2) planning to implement COVID-19 research; or 3) amending a current research study to include COVID-19 measures, please click on the survey link below to submit a description of your work and identify any resources (e.g., funding, collaborations, lab, regulatory, recruitment) that may be needed. For general questions, please email firstname.lastname@example.org.
Our goal is to remove barriers and expedite your research as we face this unprecedented health threat.
Following your submission, a research facilitator will quickly evaluate and respond to your needs. (Even if you do not require assistance with your study, please submit your information and we will catalog it in our database.)GO TO SURVEY
Research teams at the University of Pittsburgh and UPMC have mobilized to plan and implement clinical trials and clinical research studies related to COVID-19. Given the rapidity of the spread of disease, timely and efficient implementation of studies are critical to their success.
To support and facilitate these studies, we are mobilizing the Clinical and Translational Science Institute (CTSI), to help coordinate resources, expertise, research tools, and lab capabilities.
CTSI will catalogue every Pitt or UPMC COVID-19 related research protocol involving human subjects and/or associated biosamples, electronic health record and other data. This will enable Pitt and UPMC to:
- Identify collaborative opportunities among study teams
- Coordinate with HRPO to streamline regulatory submissions
- Assess researchers’ needs
- Provide research tools (e.g., electronic consents)
- Leverage expertise (e.g., study design)
- Link to institutional resources (e.g., biobanking, Health Record Research Request (R3))
- Harmonize data elements across studies
- Help provide integration with national and international research efforts
We are asking all principal investigators planning or conducting COVID-19 related studies to submit a brief description of their proposal at https://www.covid-19research.pitt.edu/.
Finally, funding opportunities are available from multiple sources. You can find details on this link same as noted above.
Please send requests for additional information, or send ideas that are not yet formed into a defined project to email@example.com.
Arthur S. Levine
Senior Vice Chancellor for the Health Sciences
Rob A. Rutenbar
Senior Vice Chancellor for Research
Steven D. Shapiro
Chief Medical and Science Officer